Naloxon B. Braun (Naloxone Hydrochloride)

Naloxone works by competitively binding to μ‑opioid receptors in the central nervous system without activating them. This displaces opioid molecules that are causing depression of the respiratory centers, allowing normal neural activity and breathing to resume within minutes.

The specific dose of Naloxon B. Braun is determined by the prescribing clinician based on the severity of the overdose, the route of administration, and patient factors. Standard emergency protocols often start with an initial dose, but exact quantities must be set by a qualified health professional.

Safety data for naloxone during pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and clinicians should weigh the emergency need against limited safety information.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Naloxon B. Braun contains naloxone, which has a rapid onset of action and a short half‑life, making it ideal for emergency reversal of opioid overdose. Alternative antagonists such as naltrexone have a longer duration but are used for maintenance therapy rather than acute reversal. The choice depends on clinical context and the need for immediate effect.

Naloxon B. Braun should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures. Do not freeze the solution, and ensure the vial is kept sealed until use to maintain sterility.

The medication is supplied as a sterile solution for intramuscular or intravenous injection. Administration is performed by a qualified healthcare professional in an emergency setting, typically using a syringe and needle appropriate for the chosen route. The injection should be given as soon as opioid overdose is suspected.

The most serious risks include precipitating acute opioid withdrawal, which can lead to severe agitation, hypertension, tachycardia, seizures, or cardiac arrhythmias. Patients with underlying cardiovascular disease may be particularly vulnerable, and close monitoring after administration is essential.

Naloxon B. Braun is contraindicated in individuals with a known hypersensitivity to naloxone or any component of the formulation. It should also be used with caution in patients with severe cardiovascular conditions, as rapid reversal of opioid effects can provoke abrupt hemodynamic changes.